Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label, Multicenter Study on the Efficacy and Safety of IgPro10 in Patients With Chronic Immune Thrombocytopenic Purpura (ITP)

NCT00168038 is registered in ClinicalTrials.gov with CSL Behring as lead sponsor.

NCT NCT00168038
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00168038 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label, Multicenter Study on the Efficacy and Safety of IgPro10 in Patients With Chronic Immune Thrombocytopenic Purpura (ITP)
Lead sponsor
CSL Behring
Phase
Phase 3
Overall status
Completed
Start date
December 31, 2004
Completion date
February 28, 2006
Enrollment
58 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

immune thrombocytopenic purpura